New survey findings highlight that narcolepsy can affect much more than daytime alertness, with many Canadians reporting lengthy delays…
Andrea Lobo, PhD
Andrea Lobo holds a PhD in cell biology/neurosciences from the University of Coimbra-Portugal, where she studied stroke biology. As a research scientist for 19 years, Andrea participated in academic projects in multiple research fields, from stroke, gene regulation, cancer, and rare diseases. She has authored multiple research papers in peer-reviewed journals.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Andrea Lobo, PhD
A wearable device using an algorithm may offer an objective way to track daytime napping and excessive daytime sleepiness (EDS)…
Tooth loss is associated with daytime sleepiness and snoring, and may also be linked to excessive sleep duration, according to…
People with narcolepsy or idiopathic hypersomnia (IH) frequently have cardiovascular, metabolic, and kidney-related conditions that may increase their vulnerability…
Use of the stimulant dexamphetamine during pregnancy to treat narcolepsy is not linked to harmful outcomes for mothers or…
People with type 1 narcolepsy (NT1) may have changes in how their brain fluid barrier functions, a new study…
A new data-driven model has identified narcolepsy — a condition characterized by the brain’s inability to regulate sleep-wake cycles…